Pharmacists in Glendale Heights, Illinois


28 Pharmacists found in Glendale Heights
female pharmacist

Nasreen Rahman, RPH


Pharmacist
1940 Flagstaff Ln, Glendale Heights, IL 60139
630-957-7523    

female pharmacist

Ngochan Ngo, PHARM.D.


Pharmacist
175 W Army Trail Rd, Att: Pharmacy, Glendale Heights, IL 60139
630-582-0065    

male pharmacist

Mr. Robert Reiner


Pharmacist
175 W Army Trail Rd, T-0836, Glendale Heights, IL 60139
630-582-0065     630-582-0065



female pharmacist

Roshni Parikh, PHARM.D


Pharmacist
175 W Army Trail Rd, Glendale Heights, IL 60139
630-582-0043     630-259-1415

female pharmacist

Rubegin F Torrevillas, PHARMD


Pharmacist
731 Terry Rd, Glendale Heights, IL 60139
630-957-8148    

female pharmacist

Samra Anjum, PHARMD


Pharmacist
2040 Glen Ellyn Rd, Glendale Heights, IL 60139
630-539-6597    

female pharmacist

Seema Patel, PHARMD.


Pharmacist
175 W Army Trail Rd, Glendale Heights, IL 60139
630-582-0065    

female pharmacist

Shriya Patel


Pharmacist
230 E North Ave, Glendale Heights, IL 60139
630-653-2137    

female pharmacist

Trang Nguyen Xuan Dinh, PHARMD


Pharmacist
2040 Glen Ellyn Rd, Glendale Heights, IL 60139
630-539-6597    

male pharmacist

Dr. Veeral Vyas, PHARMD


Pharmacist
175 W Army Trail Rd, Attn: Pharmacy, Glendale Heights, IL 60139
630-582-0065    

male pharmacist

Dr. William A Jones, PHARMD


Pharmacist
2164 Bloomingdale Rd, Glendale Heights, IL 60139
630-980-4301     630-980-4187

male pharmacist

Yong-taek Chon, PHARMD


Pharmacist
2040 Glen Ellyn Rd, Glendale Heights, IL 60139
630-539-6597     630-539-6765


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.